Free Trial

EDAP TMS S.A. (NASDAQ:EDAP) Short Interest Down 40.8% in July

Edap Tms logo with Medical background

Key Points

  • Edap Tms S.A. experienced a significant 40.8% decline in short interest from July 15th to July 31st, totaling 24,700 shares.
  • The company reported earnings of ($0.20) per share for the last quarter, missing the consensus estimate, with revenue of $16.37 million against expectations of $16.56 million.
  • Recent institutional investments include Sage Mountain Advisors acquiring a position worth $165,000 and Banque Transatlantique SA significantly increasing its stake by over 7,000% in the first quarter.
  • Five stocks to consider instead of Edap Tms.

EDAP TMS S.A. (NASDAQ:EDAP - Get Free Report) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 24,700 shares, adropof40.8% from the July 15th total of 41,700 shares. Based on an average trading volume of 51,300 shares, the days-to-cover ratio is presently 0.5 days. Currently,0.1% of the company's stock are sold short. Currently,0.1% of the company's stock are sold short. Based on an average trading volume of 51,300 shares, the days-to-cover ratio is presently 0.5 days.

EDAP TMS Stock Up 2.2%

Shares of EDAP TMS stock traded up $0.03 during trading on Friday, hitting $1.38. 46,293 shares of the stock traded hands, compared to its average volume of 68,332. The stock has a market cap of $51.60 million, a P/E ratio of -2.23 and a beta of -0.09. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.21 and a current ratio of 1.74. EDAP TMS has a twelve month low of $1.21 and a twelve month high of $4.22. The company has a fifty day moving average price of $1.50 and a two-hundred day moving average price of $1.87.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on EDAP shares. Wall Street Zen started coverage on EDAP TMS in a research report on Thursday, May 15th. They set a "hold" rating for the company. Piper Sandler lowered EDAP TMS from an "overweight" rating to a "neutral" rating in a report on Thursday, May 15th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $8.50.

View Our Latest Stock Report on EDAP

Institutional Investors Weigh In On EDAP TMS

Several institutional investors have recently made changes to their positions in EDAP. Banque Transatlantique SA lifted its holdings in shares of EDAP TMS by 7,063.7% during the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider's stock valued at $1,324,000 after buying an additional 720,499 shares during the last quarter. Scoggin Management LP bought a new position in shares of EDAP TMS in the 1st quarter valued at approximately $686,000. Sage Mountain Advisors LLC bought a new position in shares of EDAP TMS in the 2nd quarter valued at approximately $165,000. Jane Street Group LLC raised its stake in shares of EDAP TMS by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73,361 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC raised its stake in shares of EDAP TMS by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock valued at $355,000 after acquiring an additional 52,500 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors and hedge funds.

About EDAP TMS

(Get Free Report)

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

See Also

Should You Invest $1,000 in Edap Tms Right Now?

Before you consider Edap Tms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.

While Edap Tms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.